Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing
Keyword(s):
2011 ◽
Vol 126
(3)
◽
pp. 653-661
◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
Keyword(s):